Interview: Fabrizio Greco – General Manager, AbbVie Italy
Fabrizio Greco, General Manager at AbbVie Italy, discusses the successful launch of the company’s new Hepatitis C treatment, how AbbVie is seeking to position itself as a partner to the…
Abbvie is a global innovator focusing on unmet needs in the oncology, immunology, kidney disease, liver disease, neuroscience and women’s health therapeutic areas. The company’s Global CEO is Richard A Gonzales. In Italy Abbvie has a production facility at Campoverde in Aprillia which is producing part of the company’s new HCV treatment. AbbVie has been growing very strongly in Italy, with a turnover of 412 million in 2015. Globally turnover is 20 billion.
Contact
S.R. 148 Pontina Km 52 snc
04011 Campoverde di Aprilia (LT)
Telephone: +39 06 928921
Web: abbvie.it
Fabrizio Greco, General Manager at AbbVie Italy, discusses the successful launch of the company’s new Hepatitis C treatment, how AbbVie is seeking to position itself as a partner to the…
Following regulatory changes, CSL Behring is now able to offer plasma fractionation and purification services to Italy’s public healthcare sector for the first time. General manager Oliver Schmitt discusses the…
E-Pharma Trento is a pharmaceutical company specialized in development and production of niche oral delivery forms, such as soluble, effervescent, chewable and orally-disintegrating. After its foundation in 1993, E-Pharma Trento has…
PwC Italy’s Rodrigue G. Schübelin talks maintaining Italy’s impressive growth in pharma production, R&D incentives, public-private collaboration, and PwC’s role within the Italian healthcare ecosystem. Italy’s pharmaceutical production increased by…
Global skin care leader Beiersdorf is investing in developing their pharmacy channel and Gaetano Colabucci, managing director of Beiersdorf Italy, explains the importance the Internet plays in patient education and…
Having led a successful turnaround of the affiliate in just eight months, Nadia Cortesi of ResMed explains how she has achieved double digit growth, while facing sustained external challenges, including…
Despite the already existing efficiencies in the Italian healthcare system, there is still significant room for improvement. Johnson & Johnson Medical’s head for southern Europe discusses a number of opportunities…
3PL player BOMI Group went public via an IPO in June 2015. VP & CFO Marco Ruini discusses the reasons behind this Italian family company’s decision to go public, as well…
KPMG is committed to providing long-term support to public as well as private institutions as they tackle challenges and transform the way healthcare is provided. Alberto De Negri, partner of…
Angelini CEO Gianluigi Frozzi speaks about the company’s diverse portfolio of products, the “Made in Italy” brand, and the company’s continual global growth anchored strongly in innovation. Can you please give our…
As an emerging leader in mobile health and provider of innovative health-technologies, Philips is poised to provide Italian healthcare institutions with solutions that could enable significant gains in efficiency. CEO…
Biopharmaceutical logistics leader World Courier strives to understand their clients’ needs as early as possible, and the Italian affiliate has gone to unusual lengths, including joining the Italian biotech association,…
While the Italian clinical research community works to an excellent standard of quality, and is relatively competitive in terms of costs, regulatory differences with the rest of Europe pose significant…
See our Cookie Privacy Policy Here
